Evaluation of Live Trivalent Vaccine of Measles AIK-C Strain, Mumps Hoshino Strain and Rubella Takahashi Strain, by Virus-Specific Interferon-γ Production and Antibody Response

MICROBIOLOGY and IMMUNOLOGY

Volumn 34, Issue 6, 1990, Pages 497-508

  Nakayama, Tetsuo ^a,b   Urano, Takashi ^b   Osano, Mitsuru ^b   Nakagawa, Masaharu ^a   Maehara, Nobutoshi ^a   Sasaki, Keiko ^a   Yamamura, Anna M ^a   Makino, Satoshi ^a  

^a KITASATO INSTITUTE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MUMPS VACCINE; NEUTRALIZING ANTIBODY; RUBELLA VACCINE; VACCINE;

ANTIBODY DETECTION; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CYTOPATHOGENIC EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNE RESPONSE; INTERFERON INDUCTION; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MEASLES; MUMPS; PRESCHOOL CHILD; RUBELLA; SEROCONVERSION; VACCINATION;

ANTIBODIES, VIRAL; CHILD, PRESCHOOL; DRUG COMBINATIONS; EVALUATION STUDIES; HEMAGGLUTINATION, VIRAL; HUMAN; INFANT; INTERFERON TYPE II; LYMPHOCYTES; MEASLES; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; MUMPS VACCINE; RUBELLA; RUBELLA VACCINE; VACCINATION;

MEASLES VIRUS; MUMPS VIRUS; RUBELLA VIRUS;

EID: 0025149661     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1990.tb03167.x     Document Type: Article

References (27)

1. Armstrong, J.A. 1971. Semi-micro, dye-binding method for rabbit interferon. Appl. Microbiol. 21: 723-725.
2. Berger, R., and Just, M. 1983. Lack of interference between vaccines. Pediatr. Infect. Dis. 2: 172.
3. Gallagher, M.R., Welliver, R., Yamanaka, T., Eisenberg, B., Sun, M., and Ogra, P.L. 1981. Cell-mediated immune responsiveness to measles, its occurrence as a result of naturally acquired or vaccine-induced infection and in infants of immune mothers. Am. J. Dis. Child. 135: 48–51.
4. Hilleman, M., Strokes, J., Jr., Buynak, E.B., Weibel, R., Halenda, R., and Goldner, H. 1962. Enders’ live measles virus vaccine with human immune globulin. II. Evaluation of efficacy. Am. J. Dis. Child. 103: 372–379.
5. Hinman, A.R., Orenstein, W.A., Bloch, A.B., Bart, K.J., Eddins, D.L., Amler, R.W., and Kirby, C.D. 1983. Impact of measles in the United States. Rev. Infect. Dis. 5: 439–444.
6. Hirayama, M. 1983. Measles vaccines used in Japan. Rev. Infect. Dis. 5: 495–503.
7. Karchmer, A.W., Friedman, J.P., Casey, H.L., Shope, T.C., Riker, J. B., Kappelman, M.M., and Witte, J. J. 1971. Simultaneous administration of live virus vaccines, measles, mumps, poliomyelitis, and smallpox. Am. J. Dis. Child. 121: 382–388.
8. Lerman, S. J., Bollinger, M., and Brunken, J.M. 1981. Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77: DE-5 and RA27/3) virus vaccines, singly and in combination. Pediatrics 68: 18–22.
9. Makino, S. 1983. Development and characteristics of live AIK-C measles virus vaccine; a brief report. Rev. Infect. Dis. 5: 504–505.
10. Markowitz, L.E., Preblud, S.R., Orenstein, W.A., Rovira, E.Z., Adams, N.C., Hawkins, C.E., and Hinman, A.R. 1989. Patterns of transmission in measles outbreaks in the United States, 1985–1986. N. Engl. J. Med. 320: 75–81.
11. Nakayama, T. 1983. Immune-specific production of gamma interferon in lymphocyte cultures in response to mumps virus. Infect. Immun. 40: 486-492.
12. Nakayama, T., Urano, T., Osano, M., Sasaki, K., Maehara, N., Nakagawa, M., Makino, S., and Matumoto, M. 1986. Induction of gamma interferon by mumps virus in lymphocytes from children inoculated with live mumps virus vaccine. Kitasato Arch. Exp. Med. 59: 37-42.
13. Nakayama, T., Urano, T., Osano, M., Maehara, N., Sasaki, K., and Makino, S. 1987. Measles virus and mumps virus induce γ-interferon differently in human lymphocyte cultures. J. Infect. Dis. 155: 1051–1054.
14. Nakayama, T., Urano, T., Osano, M., Maehara, N., Hashimoto, H., Nakagawa, M., Sasaki, K., and Makino, S. 1987. Interferon production by human peripheral lymphocytes in response to measles virus. Kitasato Arch. Exp. Med. 60: 41–49.
15. Nakayama, T., Urano, T., Osano, M., Nakagawa, M., Maehara, N., Sasaki, K., and Makino, S. 1988. Production of interferon by human peripheral lymphocytes stimulated with rubella virus. Kitasato Arch. Exp. Med. 61: 187-193.
16. Nakayama, T., Urano, T., Osano, M., Maehara, N., Sasaki, K., and Makino, S. 1988. Long-term regulation of interferon production by lymphocytes from children inoculated with live measles virus vaccine. J. Infect. Dis. 158: 1386–1390.
17. Ofosu-Amaah, S. 1983. The control of measles in tropical Africa: a review of past and present efforts. Rev. Infect. Dis. 5: 546–553.
18. Peltola, H., and Heinonen, O.P. 1986. Frequency of true adverse reactions to measles-mumpsrubella vaccine. A double-blind placebo-controlled trial in twins. Lancet 1: 939–942.
19. Robertson, C.M., Bennett, V. J., Jefferson, N., and Mayon-White, R.T. 1988. Serological evaluation of a measles, mumps, and rubella vaccine. Arch. Dis. Child. 63: 612–616.
20. Ruckdeschel, J.C., Graziano, K.D., and Mardiney, M.R., Jr. 1975. Additional evidence that the cell-associated immune system is the primary host defense against measles (rubeola). Cell. Immunol. 17: 11–18.
21. Sasaki, K. 1974. Studies on the modification of the live AIK-C measles vaccine. I. Adaptation of the further attenuated AIK-C measles virus (the strain AIK-L33) to chick embryo cells. Kitasato Arch. Exp. Med. 47: 1–12.
22. Sasaki, K., Higashihara, M., Inoue, K., Igarashi, Y., and Makino, S. 1976. Studies on the development of a live attenuated mumps virus vaccine. I. Attenuation of the Hoshino “wild” strain of mumps virus. Kitasato Arch. Exp. Med. 49: 43–52.
23. Shimazaki, T. 1988. Studies on the establishment of measles antibodies detection method using enzyme-linked immunosorbent assay (ELISA), J. Jpn. Assoc. Infect. Dis. 62: 1157–1165 (in Japanese).
24. Tingle, A.J., Chantler, J.K., Kettyls, G.D., Larke, R.P.B., and Schulzer, M. 1985. Failed rubella immunization in adults: association with immunologic and virological abnormalities. J. Infect. Dis. 151: 330–336.
25. Tuji, M., Sasaki, K., Nakagawa, M., Mori, T., Nakayama, T., Makino, S., and Okamura, M. 1983. Improved enzyme-linked immunosorbent assay (ELISA) for the detection of mumps virus antibodies. Kitasato Arch. Exp. Med. 56: 137–147.
26. Vesikari, T., Ala-Laurila, E.L., Heikkinen, A., Terho, A., D’Hondt, E., and Andre, F.E. 1984. Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children. Am. J. Dis. Child. 138: 843–847.
27. Yamane, Y., Nagashima, T., Asahara, T., Nagamine, T., Kawakubo, Y., Kimura, M., Ikumi, H., Matsubara, A., Ohwada, Y., Hashimoto, T., Mizunoe, K., Ishiguro, Y., Kimura, K., Kokubo, Y., Horiuchi, K., Sunaga, H., and Sawada, K. 1974. Studies on the live attenuated rubella virus vaccine. III. Clinical trials with rubella virus (Takahashi strain) vaccine in children and women. Kitasato Arch. Exp. Med. 47: 89–100.